Abstract:Abstract Microbes typically live in complex habitats where they need to rapidly adapt to continuously changing growth conditions. To do so, they produce an astonishing array of natural products with diverse structures and functions. Actinobacteria stand out for their prolific production of bioactive molecules, including antibiotics, anticancer agents, antifungals, and immunosuppressants. Attention has been directed especially towards the identification of the compounds they produce and the mining of the large diversity of biosynthetic gene clusters (BGCs) in their genomes. However, the current return on investment in random screening for bioactive compounds is low, while it is hard to predict which of the millions of BGCs should be prioritized. Moreover, many of the BGCs for yet undiscovered natural products are silent or cryptic under laboratory growth conditions. To identify ways to prioritize and activate these BGCs, knowledge regarding the way their expression is controlled is crucial. Intricate regulatory networks control global gene expression in Actinobacteria, governed by a staggering number of up to 1000 transcription factors per strain. This review highlights recent advances in experimental and computational methods for characterizing and predicting transcription factor binding sites and their applications to guide natural product discovery. We propose that regulation-guided genome mining approaches will open new avenues toward eliciting the expression of BGCs, as well as prioritizing subsets of BGCs for expression using synthetic biology approaches. One-Sentence Summary This review provides insights into advances in experimental and computational methods aimed at predicting transcription factor binding sites and their applications to guide natural product discovery.

Next Generation Sequencing of Actinobacteria for the Discovery of Novel Natural Products

Targeting Bacterial Genomes for Natural Product Discovery

Genomics-Driven Natural Product Discovery in Actinomycetes.

Targeted Genome Mining—From Compound Discovery to Biosynthetic Pathway Elucidation

The Natural Products Discovery Center: Release of the First 8490 Sequenced Strains for Exploring Actinobacteria Biosynthetic Diversity

Natural Products from Actinobacteria for Drug Discovery

Harnessing regulatory networks in Actinobacteria for natural product discovery

Comparative genomics of actinomycetes with a focus on natural product biosynthetic genes

Genome Mining Enabled by Biosynthetic Characterization Uncovers a Class of Benzoxazolinate‐Containing Natural Products in Diverse Bacteria

Recent Advances in Synthetic Biology Approaches to Optimize Production of Bioactive Natural Products in Actinobacteria

Sequencing rare marine actinomycete genomes reveals high density of unique natural product biosynthetic gene clusters

Next-generation synthetic biology approaches for the accelerated discovery of microbial natural products

Genome Mining as New Challenge in Natural Products Discovery

A treasure trove of 1034 actinomycete genomes

Strain improvement in actinomycetes in the postgenomic era

A treasure trove of 1,034 actinomycete genomes

Genome mining and prospects for antibiotic discovery

Strategies for Natural Products Discovery from Uncultured Microorganisms

Biosynthesis of C-nucleoside antibiotics in actinobacteria: recent advances and future developments

Genome mining of rare actinomycetes and cryptic pathway awakening

Advances in mining and expressing microbial biosynthetic gene clusters